Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States
Related Posts
Ansari S, Pourafkari L, Kinninger A, Budoff MJ. Association of ramus intermedius with greater overall coronary plaque and stenosis burden. Int J Cardiovasc Imaging. 2026[...]
Ansari S, Budoff MJ. Non-calcified plaque volume assessed by coronary computed tomographic angiography: prognostic significance, reproducibility, and temporal progression. Eur Heart J Imaging Methods Pract.[...]
Coppola JA, Barforoshi S, Chung J, Jone PN, Kulkarni A, Co-Vu J. Structural Heart Interventions in Women with Congenital Heart Disease. Curr Cardiol Rep. 2026[...]